Immunic IMUX
NASDAQ IMUX
$7.96 -0.68 (-7.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunic (IMUX) Return on Equity [ROE] (2014 - 2026)

Updated

Immunic (IMUX) reported Return on Equity [ROE] of -82.65% for Q2 2026, up 641.47 percentage points from -724.12% a year earlier and up 66.80 percentage points from the prior quarter.

Analysis

Immunic (IMUX) Return on Equity [ROE] (2014 - 2026) Analysis & Trends

For FY2025, Immunic posted Return on Equity [ROE] of -1738.48%, down 1338.73 percentage points from FY2024.

  • Return on Equity [ROE] has declined for five consecutive years, with a five-year change of -1693.43 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -399.76% in FY2024 (-264.92 pp), -134.84% in FY2023 (-36.46 pp), -98.38% in FY2022 (-34.30 pp) and -64.08% in FY2021 (-19.03 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q3 2022.
  • Year over year, Return on Equity [ROE] gained in three of the last eight quarters, with an average year-over-year change of -660.90 percentage points.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q1 2026 (a gain of 1351.24 percentage points); the low point was Q4 2025 (a drop of 5024.36 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -149.45% (Q1 2026), -5341.77% (Q4 2025) and -469.53% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Immunic 338.41 Mn 338.41 Mn - -82.65%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -82.65%
Mar 31, 2026 -149.45%
Dec 31, 2025 -5,341.77%
Sep 30, 2025 -469.53%
Jun 30, 2025 -724.12%
Mar 31, 2025 -1,500.68%
Dec 31, 2024 -317.40%
Sep 30, 2024 -176.16%
Jun 30, 2024 -122.53%
Mar 31, 2024 -164.24%
Dec 31, 2023 -248.64%
Sep 30, 2023 -220.81%
Jun 30, 2023 -158.28%
Mar 31, 2023 -120.52%
Dec 31, 2022 -106.47%
Sep 30, 2022 -70.59%
Jun 30, 2022 -61.71%
Mar 31, 2022 -60.86%
Dec 31, 2021 -67.21%
Sep 30, 2021 -63.16%
API Access

Immunic Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMUX&period=max&api_key=YOUR_API_KEY